These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7387853)

  • 1. Distant metastasis facilitated by BCG: spread of tumour cells injected in the BCG-primed site.
    Ishibashi T; Yamada H; Harada S; Harada Y; Miyazaki N; Takamoto M; Watanabe K
    Br J Cancer; 1980 Apr; 41(4):553-61. PubMed ID: 7387853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition and promotion of tumor growth by BCG: evidence for stimulation of humoral enhancing factors by BCG.
    Ishibashi T; Yamada H; Harada S; Harada Y; Takamoto M; Sugiyama K
    Int J Cancer; 1978 Jan; 21(1):67-71. PubMed ID: 624600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy of primary methylcholanthrene-induced mouse tumours by intratumoral BCG.
    Creau-Goldberg N; Salomon JC
    Br J Cancer; 1980 Apr; 41(4):541-52. PubMed ID: 7387852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responses of tumors induced in inbred guinea pig strain JY=1 and strain Hartley/F to BCG.
    Kataoka T; Tokunaga T; Murohashi T
    J Natl Cancer Inst; 1977 Mar; 58(3):803-8. PubMed ID: 320348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCG immunotherapy of a rat sarcoma.
    Baldwin RW; Pimm MV
    Br J Cancer; 1973 Oct; 28(4):281-7. PubMed ID: 4759936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased resistance in splenectomized mice to a methylcholanthrene-induced tumour.
    Chang RW; Turk JL
    Br J Cancer; 1977 Jun; 35(6):768-76. PubMed ID: 871366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour inhibition mediated by BCG in immunosuppressed rats.
    Moore M; Lawrence N; Nisbet NW
    Int J Cancer; 1975 Jun; 15(6):897-911. PubMed ID: 1150345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastasis formation after intravenous tumour cell injection in thrombocytopenic rats.
    Ivarsson L
    Eur Surg Res; 1976; 8(1):51-60. PubMed ID: 1248501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible role of macrophage-like suppressor cells in the anti-tumour activity of BCG.
    Castés M; Lynch NR; Lespinats G; Orbach-Arbouys S
    Br J Cancer; 1981 Dec; 44(6):828-37. PubMed ID: 6459797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L; Hunter N; Mason K; Withers HR
    Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunopotentiation with BCG: dimensions of a specific antitumor response.
    Hawrylko E
    J Natl Cancer Inst; 1975 May; 54(5):1189-97. PubMed ID: 805254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of experimental pulmonary metastasis and inhibition of subcutaneously transplanted tumor growth following cryosurgery.
    Shibata T; Yamashita T; Suzuki K; Takeichi N; Micallef M; Hosokawa M; Kobayashi H; Murata M; Arisue M
    Anticancer Res; 1998; 18(6A):4443-8. PubMed ID: 9891507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunospecific regression of methylcholanthrene fibrosarcoma using neuraminidase. 3. Synergistic effect of BCG and neuraminidase treated tumor cells.
    Simmons RL; Rios A
    Ann Surg; 1972 Aug; 176(2):188-94. PubMed ID: 4562008
    [No Abstract]   [Full Text] [Related]  

  • 14. Site-induced differences in spontaneous metastasis of MO4 mouse fibrosarcoma cells.
    Meyvisch C; Mareel M
    Invasion Metastasis; 1985; 5(4):185-92. PubMed ID: 4008191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of peritoneal exudate cells induced by cell-wall skeleton of Mycobacterium bovis BCG.
    Namba M; Ogura T; Hirao F; Azuma I; Yamamura Y
    Gan; 1978 Dec; 69(6):831-4. PubMed ID: 374173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The immunopotentiating action of BCG and its various effects on tumors (author's transl)].
    Yamada H
    Kekkaku; 1978 Jan; 53(1):11-23. PubMed ID: 633697
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanism of Bacillus Calmette-Guérin-induced suppression of metastases in a poorly immunogenic fibrosarcoma.
    Liotta LA; Kleinerman J; Saidel GM
    Cancer Res; 1976 Sep; 36(9 pt.1):3255-9. PubMed ID: 788897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and immunologic characterization of 3-methylcholanthrene-induced sarcoma cell lines metastasizing widely in mice and exhibiting distinct and selective propensities for the mode of metastasis.
    Kodama Y; Seyama T; Kamiya K; Yokoro K
    J Natl Cancer Inst; 1982 Sep; 69(3):595-605. PubMed ID: 7050499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCG immunotherapy of rat tumors of defined immunogenicity.
    Baldwin RW; Pimm MV
    Natl Cancer Inst Monogr; 1973 Dec; 39():11-9. PubMed ID: 4595312
    [No Abstract]   [Full Text] [Related]  

  • 20. BCG immunotherapy of pulmonary growths from intravenously transferred rat tumour cells.
    Baldwin RW; Pimm MV
    Br J Cancer; 1973 Jan; 27(1):48-54. PubMed ID: 4686177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.